Aspirin/Lansoprazole

阿司匹林/兰索拉唑

Report date: 2026/01/13 14:23:48

Base Information

Drug NameAspirin/Lansoprazole
Drug Alias NameLansoprazole/Aspirin阿司匹林•兰索拉唑Lansoprazole and Aspirin阿司匹林和兰索拉唑Aspirin•Lansoprazole +[13] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsProton pump inhibitors
TargetsProton pumpCyclooxygenases
Therapy Area/IndicationsThromboembolismMyocardial InfarctionAngina Pectoris +[6] 
Global Approved IndicationsThromboembolismMyocardial InfarctionAngina Pectoris +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2014/03/24
Country/TerritoryJapan
CombinationsYes AspirinLansoprazole
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsThromboembolismMyocardial InfarctionAngina Pectoris +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeA02BC53B01AC56
Related LinksKEGG